Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Priscilla Hollander(Baylor University Medical Center), Colleen Burns(VistaGen Therapeutics (United States)), Raymond A Plodkowski(University of California San Diego), Harold Bays(Louisville Metabolic and Atherosclerosis Research Center), Preston Klassen(Amgen (United States)), Ken Fujioka(Scripps Clinic), Alok Gupta(Government of India), Frank L. Greenway(Pennington Biomedical Research Center)
Cited by 494
Related Papers
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
|Journal of the American Society of Nephrology|2004|2.7k
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
|Endocrine Practice|2016|1.8k